Pär Hallberg Selected Research

Pär Hallberg Research Topics

Disease

9	Drug-Related Side Effects and Adverse Reactions 10/2020 - 09/2010
6	Femoral Fractures (Femoral Fracture) 01/2019 - 08/2014
4	Rheumatoid Arthritis 10/2021 - 01/2016
4	Angioedema 01/2021 - 02/2005
4	Heart Failure 12/2020 - 02/2003
4	Agranulocytosis (Granulocytopenia) 10/2020 - 01/2016
4	Osteonecrosis (Kienbock's Disease) 01/2016 - 12/2013
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2008 - 10/2002
3	Anxiety Disorders (Anxiety Disorder) 09/2010 - 02/2005
3	Essential Hypertension 03/2004 - 10/2002
2	Pancreatitis 01/2022 - 04/2004
2	Hypertension (High Blood Pressure) 12/2020 - 07/2008
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 01/2019
2	Neutropenia 10/2020 - 01/2020
2	Chemical and Drug Induced Liver Injury 11/2019 - 01/2018
2	Neoplasms (Cancer) 01/2019 - 01/2016
2	Muscular Diseases (Myopathy) 01/2019 - 01/2018
2	Rhabdomyolysis 01/2019 - 01/2018
2	Cough 04/2017 - 02/2017
2	Hypertrophy 03/2004 - 03/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Diabetes Complications 12/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2019
1	Hypersensitivity (Allergy) 11/2019
1	Cicatrix (Scar) 11/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019
1	Narcolepsy 02/2019
1	Orthomyxoviridae Infections 02/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Kidney Calculi (Kidney Stone) 01/2018
1	Multiple Sclerosis 01/2018
1	Osteoporotic Fractures 03/2016
1	Hyperthyroidism 01/2016
1	Multiple Myeloma 01/2016
1	Prodromal Symptoms 09/2015
1	Exfoliative Dermatitis (Erythroderma) 04/2014
1	Alcoholism (Alcohol Abuse) 04/2014
1	Gingival Recession 03/2014

Drug/Important Bio-Agent (IBA)

8	Diphosphonates (Bisphosphonates)IBA 01/2019 - 12/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 04/2004
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 02/2017
4	Atenolol (Tenormin)FDA LinkGeneric 07/2008 - 10/2002
4	Irbesartan FDA LinkGeneric 07/2008 - 10/2002
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 07/2019
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2009 - 02/2005
3	Antihypertensive Agents (Antihypertensives)IBA 07/2008 - 03/2003
2	EnzymesIBA 10/2021 - 07/2019
2	Alanine Transaminase (SGPT)IBA 10/2021 - 07/2019
2	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2021 - 03/2003
2	ORALIT (ORS)IBA 01/2021 - 01/2016
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 04/2017
2	Dipyrone (Metamizole)IBA 10/2020 - 01/2020
2	Carbamazepine (Tegretol)FDA LinkGeneric 11/2019 - 04/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2018
2	HLA-B Antigens (HLA-B)IBA 01/2018 - 01/2016
2	BradykininIBA 02/2017 - 03/2003
2	Digoxin (Digitek)FDA LinkGeneric 10/2007 - 02/2003
2	Angiotensin IIIBA 03/2004 - 03/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2022
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2022
1	HLA-DRB1*07 antigenIBA 01/2022
1	MMEIBA 12/2020
1	Protein Kinase C-thetaIBA 12/2020
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 12/2020
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	HLA-A31 antigenIBA 11/2019
1	HLA-B57 antigenIBA 11/2019
1	Nerve Growth Factors (Neurotrophins)IBA 02/2019
1	pandemrixIBA 02/2019
1	Untranslated RNA (Noncoding RNA)IBA 02/2019
1	Genetic Markers (Genetic Marker)IBA 02/2019
1	HLA-DQB1 antigen (HLA DQB1)IBA 02/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 02/2019
1	Floxacillin (Flucloxacillin)IBA 01/2018
1	Fusidic Acid (Fucithalmic)IBA 01/2018
1	InterferonsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	LipidsIBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	Gemfibrozil (Lopid)FDA LinkGeneric 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	CarbimazoleIBA 01/2016
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2016
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016
1	Propylthiouracil FDA Link 01/2016
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2016
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2014

Therapy/Procedure

3	Therapeutics 01/2018 - 03/2014
1	Prostheses and Implants (Prosthesis) 01/2016
1	Drug Therapy (Chemotherapy) 01/2016
1	Intravenous Administration 01/2016
1	Dental Prosthesis 01/2016